Tuesday 6 July 2021
Panacea gains on DCGI nod for Sputnik V
Panacea Biotec has received a licence from the Drugs Controller General of India (DCGI) to manufacture Sputnik V, a development that saw the shares of
from The Hindu - Business
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment